chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shot 1: sore arm and bouts of fatigue during three-week interim. Period is longer (9 days) and more painful than usual. PMS symptoms also endure for most of my bleeding, and bleeding becomes more heavy on day 4, as if I had a "second" period. Shot 2: 8 hours post shot, awakened with slight body aches. The body aches progressed to fever, headache and nausea between post-vaccine hours 8 to 12. From hours 12-27, I experienced a fever of 100, vomiting, diarrhea, body aches, chills, and insomnia. Fever initially not affected by tylenol or ibuprofen. I cycled tylenol and ibuprofen throughout the day. At hour 27 post-vaccination I was able to take 3 ibuprofen and slept for 3 hours. Woke up at hour 31 and fever was gone for good. Days 2-6 post-vaccine, experienced headache and joint pain concentrated on the side of shot. There was a bruise just beneath the shot that turned green and is still visible 11 days post-vaccine. Bouts of fatigue have not ceased since first vaccine. Onset of period is currently delayed by 4 days.
Patient was given vaccine to soon. Received in July 2018 and not to receive until November 2018.
Sick as a dog; Arm was swollen; Shortness of breath; Nasal problem; Nose has been runny since january; Loss of appetite; Has red marks on the arm/Color has still not come back or returned yet; Had reaction to the booster dose; Sinus problem; Feeling weak; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (Sick as a dog), PERIPHERAL SWELLING (Arm was swollen), DYSPNOEA (Shortness of breath), NASAL DISCOMFORT (Nasal problem) and RHINORRHOEA (Nose has been runny since january) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003J21-2A, 032B21A and 001C21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     It was reported that patient had no past medical history or allergies. It was reported that patient had not experienced symptoms in the past before receiving the Moderna COVID-19 vaccine.  It was reported that there was no history of Myocarditis/pericarditis.  It was reported that there was no history of COVID-19 infection.  It was reported that patient had no positive covid test or diagnosis.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for Heart disease, unspecified, FISH OIL for an unknown indication.   On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2022, the patient experienced ILLNESS (Sick as a dog), PERIPHERAL SWELLING (Arm was swollen), DYSPNOEA (Shortness of breath), NASAL DISCOMFORT (Nasal problem), RHINORRHOEA (Nose has been runny since january), DECREASED APPETITE (Loss of appetite), ERYTHEMA (Has red marks on the arm/Color has still not come back or returned yet), IMMUNISATION REACTION (Had reaction to the booster dose), SINUS DISORDER (Sinus problem) and ASTHENIA (Feeling weak). At the time of the report, ILLNESS (Sick as a dog), PERIPHERAL SWELLING (Arm was swollen), DYSPNOEA (Shortness of breath), NASAL DISCOMFORT (Nasal problem), RHINORRHOEA (Nose has been runny since january), DECREASED APPETITE (Loss of appetite), ERYTHEMA (Has red marks on the arm/Color has still not come back or returned yet), IMMUNISATION REACTION (Had reaction to the booster dose), SINUS DISORDER (Sinus problem) and ASTHENIA (Feeling weak) had not resolved.            Concomitant medications also included vitamins.  It was stated by the patient that she had lost her job as her work thought that it was covid, but patient stated that she did not had covid.  It was stated that timeline of symptoms including cardiac lab values (ECG, cardiac test, cardiac enzymes) was not obtained.  The patient stated that she only went to the emergency room but was not hospitalized.  Patient had went to Emergency room where she had received the treatment and got a shot in the hip (buttocks).
SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
Janssen COVID-19 vaccine EUA- Patient called unit at 1605, she was administered the J&J vaccine on Friday 7/9/21 at a health unit, She waited in clinic X15 minute  after vaccination with no side effects felt before leaving. States that evening 7/9/21 she experienced being flushed, muscle aches, HA, chills and fever of 101.  On 7/10/21 she decided to go have dinner with friends. States while driving, she felt flushed again and her vision blurry. Stated she passed out at the wheel and was in a car accident, occurred around 12PM. Was taken to ER for observation. She wanted to let us know of situation.
Increase in swelling leg- 1 1/4" larger left leg; Extensive redness - most of thigh; Limping occurred within 6 hours after injection
Day 8 post vaccination patient started with rash on arm of vaccination. Rash also appeared  right breast, stomach and small of back. Shown on 1/25/2021  Patient reported as VERY itchy.
Shingles vaccine in left arm, Tdap at same time in that arm.   Right arm:  Pneumonia.    She got her vaccine, had 4 shots in the left arm and one in the right.  She went home about 3 hours later and collapsed, was unconscious for about 8 minutes (reported by mom).  She did not go to the doctor that night and went the next day.  She could no breath right, couldn't figure out what it was at first.  It then became red and hot, swelled to the size of the foot.  She was admitted to Hospital.  While she was in the hospital her temperature was high, she was convulsing, and does not remember the first 3-4 days but was informed that they packed her in ice to get her temperature down.  it still would not break and her heart rate was not good and the doctor came in while she was convulsing and told her he was worried and gave her antibiotics despite having colitis.  They treated her with 8 different antibiotics and antiviral medications and got it done to one antibiotic.  She was on multiple for a couple of days.  Then they said to take her off of all of them except the working one.  She was then discharged home with some medications and got her taken care of while in the hospital.  She now has recovered completely.  She was informed that she had fluid around her lungs, but her heart was okay.
Information has been received from a health professional concerning her 8 year old daughter with asthma and a known drug allergy to amoxicillin trihydrate (+) clavulanate potassium (Augmentin) who in 06/95 was vaccinated with varicella virus vaccine live. Concomitant therapy included budesonide (Pulmicort) and albuterol (Ventilan). On 06/06/01, the pt experienced chicken pox with about 100 to 150 vesicles lesions. It was noted that other symptoms included lethargy and decreased appettite
EPISTAXIS; SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient (health care professional) via other manufacturer (Pfizer) concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: unspecified drug allergy, and other pre-existing medical conditions included: The patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1)(suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total administered at left arm on 01-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 40 years old. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (Dose number in series 1)  The patient additionally received non-company suspect vaccine included: Moderna (elasomeran) (spikevax) (Dose number in series 2) (form of admin, route of admin, batch number and expiry date were not reported) dose was not reported, administered at left arm on 07-JAN-2022 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (Dose number in series 2). Concomitant medications included Garlic (allium sativum), Calcium magnesium and zinc plus D3. (calcium/colecalciferol/magnesium/zinc), cetirizine, Vitamin D3 (colecalciferol), Turmeric Curcumin(curcuma longa), dextromethorphan hydrobromide/guaifenesin/phenylephrine hydrochloride, diphenhydramine, fish oil, ibuprofen, norethisterone, Psyllium fiber (plantago ovata husk fibre), Black Elderberry (sambucus nigra), Super Vitamin B complex (vitamin b complex) and epicor. On unspecified date in APR-2023, the patient experienced suspected covid-19 infection (Dose number in series 2) and received non-company suspect drugs Paxlovid (nirmatrelvir/ritonavir) (form of admin, route of admin was not reported, batch number: GG2523 expiry: UNKNOWN) dose and frequency were not reported from 10-APR-2023 to 11-APR-2023 for covid-19 treatment. On 11-APR-2023 at 09:15, the patient experienced epistaxis-nose bleed persistent from right nostril (Dose number in series 2) lasting over 1 hour. Happened after taking first dose Paxlovid. Patient was taking other medications within 2 weeks of starting COVID-19 treatment. The action taken with covid-19 vaccine ad26.cov2.s, and elasomeran was not applicable; and action taken with nirmatrelvir/ritonavir was not reported. The patient was recovering from epistaxis, and the outcome of suspected covid-19 infection and revaccination with different covid-19 vaccine was not reported. This report was non-serious.
01/15/22 Covid symptoms started with a cough and a sore throat and that's all that was going on. We had planned a trip for a cruise and took a test on 01/17 and the results were inconclusive, and on 01/20 I retested and was positive. 01/29 I went to the hospital locally after having dizziness and they did an MRI and drew blood and they said I had a Covid stroke and they said they had seen a lot of people with neurological problems after testing positive. I had gotten dizzy and couldn't hold myself up and thought it was my high blood pressure. I'm not having dizziness now and I'm doing some physical therapy and I check my blood pressure everyday. I do have some follow up appointments to take care of but that's about it. I don't have any Covid symptoms or trouble breathing either.
little tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "little tired".  Additional information: No reaction to Shots 1 and 2 except a little tired.  Follow-up attempts are completed. No further information is expected.
I was sick for like about 24 hours; I have been getting headaches slightly; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: EW0176), via an unspecified route of administration on an unspecified date (on Tuesday) in 2021, as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on an unspecified date, as single dose for covid-19 immunisation. On an unspecified date in 2021, after the vaccination, the patient was sick and experienced headache. The clinical course of the event as follows: the patient got the second dose of the Pfizer vaccine (Unspecified vaccine) on Tuesday and she was sick for like about 24 hours and then I felt fine, but she had been getting headaches slightly since then. The patient was wondering whether it was normal side effect or not. The events were reported as non-serious. On an unspecified date in 2021, the patient was resolved from the sickness. The outcome of the other event was unknown.   Information on Lot/Batch number was available. Additional information has been requested.
My heart starting skipping beats and fluttering, month (October) long cold, and stomach flu (September)
arm pain after carrying 5-10 pounds items; Joint pain/Left shoulder pain; Muscle pain/whole upper body hurting; Chest pain; Leg pain/arm pain/left arm pain; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest pain), PAIN IN EXTREMITY (Leg pain/arm pain/left arm pain), PAIN IN EXTREMITY (arm pain after carrying 5-10 pounds items), ARTHRALGIA (Joint pain/Left shoulder pain) and MYALGIA (Muscle pain/whole upper body hurting) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Leg pain/arm pain/left arm pain) and HEADACHE (Headache). On 20-Apr-2021, the patient experienced CHEST PAIN (Chest pain), ARTHRALGIA (Joint pain/Left shoulder pain) and MYALGIA (Muscle pain/whole upper body hurting). On 14-Jun-2021, the patient experienced PAIN IN EXTREMITY (arm pain after carrying 5-10 pounds items). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, CHEST PAIN (Chest pain) and HEADACHE (Headache) outcome was unknown and PAIN IN EXTREMITY (Leg pain/arm pain/left arm pain), PAIN IN EXTREMITY (arm pain after carrying 5-10 pounds items), ARTHRALGIA (Joint pain/Left shoulder pain) and MYALGIA (Muscle pain/whole upper body hurting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient has had multiple types of testing including blood, autoimmune and neurological testing.  No concomitant medications were reported by the reporter. No treatment medications were reported by the reporter.
sore arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-089248 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up was received on 28 MAY2021 included reporter details were updated.
armpit is very sore; armpit is super itchy; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (armpit is very sore) and PRURITUS (armpit is super itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (armpit is very sore) and PRURITUS (armpit is super itchy). At the time of the report, AXILLARY PAIN (armpit is very sore) and PRURITUS (armpit is super itchy) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
the third dose of VAQTA; using another unspecified vaccine for Hepatitis Bat that time; HAVRIX on 5/22/2018; Information has been received from a pharmacist referring to a 73 years old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  The initial dose of Hepatitis A vaccination was hepatitis a virus vaccine inactivated (HAVRIX) (lot number PZ353, expiration date 21-NOV-2020) administered on 22-MAY-2018, and the second dose was Hepatitis A Vaccine, Inactivated (VAQTA) (lot number R 027987, expiration date 09-AUG-2019) intramuscularly for prophylaxis on 18-DEC-2018 (reported as 7 months later) (inappropriate schedule of product administration). On 20-FEB-2019, the patient received the third dose of Hepatitis A vaccine, which was VAQTA (lot number R031045, expiration date 18-NOV-2019) (inappropriate schedule of product administration). There was a medical error as per pharmacist, the office was using another unspecified vaccine for Hepatitis B at that time (wrong product administered). No product quality complaint (PQC) was involved.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 56 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing), notes: Other medical history: Hypothyroidism, high cholesterol; "high cholesterol" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID, on 22Apr2022; ROSUVASTATIN, on 22Apr2022. Past drug history included: Tetracycline, reaction(s): "known allergies: Tetracycline", notes: known allergies: Tetracycline; Lactose, reaction(s): "known allergies:Lactose", notes: known allergies:Lactose. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Mild Fuzzy head, light headed Narrative:  occurred for only that night after the vaccine
Severe eczema.  Dairy still causes outbreaks and an egg allergy has been discovered.  Eczema treated with hydro-cortisone cream.
i AM SURE THAT i AM HAVING SHORT TERM MEMORY LOSS. i USED TO BE ABLE TO REMEBER THINGS, DIMINTIA DOESNT RUN IN MY FAMILY. I FORGET CONVERSATIONS, WHERE IM GOING AND EVEN SIMPLE PLANS ITS ONLY SHORT TERM, BECAUSE I CAN REMEBER THINGS FROM A WHILE BACK BUT THE SHORT TERM MEMORY ISSUE ISNT EXTREMELY CONSISTENT BUT I FORGET THE DAYS, I AM REALLY STARTING TO TRY TO REMBER BUT SOMETIMES I JUST CANT SEEM TO REMEMBER. I AM NOT SURE IF THIS IS A SIDE EFFECT BUT IF IT IS CAN YOU LEAD ME TO A DOCTOR WHO CAN HELP ME.
Cramping in arm, hand, and legs in a 53 year old male receiving Lymerix for prevention. This report was received from pt and confirmed by physician with follow-up medical record. His left deltoid are hurt for 32-48 hours post vax. then while taking a shower, at 08:00, he felt "waves of tingling sensation all over his body, and he went down onto his knees." He stated that he experienced cramping (muscle spasms) in his left arm, hand and "he thought" his legs. This lasted for 15-30 seconds. He confirmed that he was alert and aware of his surroundings at all times. The physician confirmed that the account of the events provided by the pt to SB was identical to that reported to him. The reporting physician does not consider these events to represent a seizure. He reported that an MRI show multiple areas in the white matter of increased signal, which did not enhance with gadolinium in the white matter. The pt complained of leg weakness not confirmed by strength testing upon physical exam. He complained of a tingling paresthesia in the radial nerve distribution of the right upper extremity extending distally form the mid-forearm. Referred to a neurologist who examined him on 06/09. It is not know if the pt underwent lumbar puncture. The reporting physician considers the differential dx to include multiple sclerosis, although he emphasized that the pt's current dx remains uncertain. Arm paresthesias is improving but ongoing. The neurologist was suspicious of a "mild post-vaccinal related demyelinative syndrome." Symptoms are improving with time consistent with monophasic illness. Neurologist stated, "It seemed reasonable that the pt may have been genetically susceptible to a post-vaccinal demyelination sydrome in view of mother with lupus." Outcome of event is ongoing.
I?m having itchiness at the injection site and slightly around the injection site. I am able to  refrain from scratching the area.  It it just enough to let me know that it?s there.  I am going to take a Zyrtec/Claritin to see if it will stop.  I have no allergies.
Patient consumed sweet potatoes one day after vaccine - has had sweet potatoes from same batch several times w/o reaction. Within 2 hours, was vomiting and lethargic. Slept for several hours, limited intake of breast milk. Fully recovered in approximately 8 hours. Also experienced rhinorrhea. Dr. suspected food protein-induced enterocolitis syndrome.